Transglutaminase-2 regulation by arecoline in gingival fibroblasts

Journal of Dental Research

Volumn 88, Issue 2, 2009, Pages 170-175

  Thangjam, G S ^a   Agarwal, P ^a   Khan, I ^a   Verma, U P ^b   Balapure, A K ^c   Rao, S G ^d   Kondaiah, P ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

^d RV Dental College and Hospital   (India)

Author keywords

Arecoline; Muscarinic acetylcholine receptor; Oral submucous fibrosis; Transglutaminase 2

Indexed keywords

8 BROMO CYCLIC AMP; ARECOLINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC M2 RECEPTOR; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; SCLEROPROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; FIBROBLAST; GINGIVA; HUMAN; METABOLISM; MOUTH DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ARECOLINE; BLOTTING, WESTERN; CELLS, CULTURED; ENZYME INDUCTION; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; GINGIVA; GTP-BINDING PROTEINS; HUMANS; ORAL SUBMUCOUS FIBROSIS; RECEPTOR, MUSCARINIC M2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSGLUTAMINASES;

EID: 62649115017     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/0022034508329633     Document Type: Article

References (23)

1. Bowness JM, Venditti M, Tarr AH, Taylor JR (1994). Increase in epsilon(gamma-glutamyl)lysine crosslinks in atherosclerotic aortas. Atherosclerosis 111:247-253. (Pubitemid 124011372)
2. Brooker G, Harper JF, Terasaki WL, Moylan RD (1979). Radioimmunoassay of cyclic AMP and cyclic GMP. Adv Cyclic Nucleotide Res 10:1-33.
3. Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS (2002). Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38:195-200.
4. Chu NS (2001). Effects of betel chewing on the central and autonomic nervous systems. J Biomed Sci 8:229-236. (Pubitemid 32511106)
5. Felder CC (1995). Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J 9:619-625.
6. Foissier L, Lonchampt M, Coge F, Canet E (1996). In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor. J Pharmacol Exp Ther 278:1484-1490. (Pubitemid 27167003)
7. Folk JE, Cole PW (1966). Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim Biophys Acta 122:244-264.
8. Genestra M (2007). Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 19:1807-1819.
9. Ghelardini C, Galeotti N, Lelli C, Bartolini A (2001). M1 receptor activation is a requirement for arecoline analgesia. Farmaco 56:383-385. (Pubitemid 32622103)
10. Griffin M, Casadio R, Bergamini CM (2002). Transglutaminases: nature's biological glues. Biochem J 368(Pt 2):377-396.
11. Harvey W, Scutt A, Meghji S, Canniff JP (1986). Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31:45-49.
12. Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY (1999). Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol 37:751-756.
13. Johnson TS, Skill NJ, El Nahas AM, Oldroyd SD, Thomas GL, Douthwaite JA, et al. (1999). Transglutaminase transcription and antigen translocation in experimental renal scarring. J Am Soc Nephrol 10:2146-2157.
14. Mirza A, Liu SL, Frizell E, Zhu J, Maddukuri S, Martinez J, et al. (1997). A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-kappaB. Am J Physiol 272(2 Pt 1):G281-G288. (Pubitemid 27137241)
15. Ndoye A, Buchli R, Greenberg B, Nguyen VT, Zia S, Rodriguez JG, et al. (1998). Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Dermatol 111:410-416. (Pubitemid 28400086)
16. Nigam M, Ranjan V, Srivastava S, Sharma R, Balapure AK (2008). Centchroman induces G0/G1 arrest and caspase-dependent apoptosis involving mitochondrial membrane depolarization in MCF-7 and MDA MB-231 human breast cancer cells. Life Sci 82:577-590.
17. Oakley E, Demaine L, Warnakulasuriya S (2005). Areca (betel) nut chewing habit among high-school children in the Commonwealth of the Northern Mariana Islands (Micronesia). Bull World Health Organ 83:656-660. (Pubitemid 41297068)
18. Shieh DH, Chiang LC, Shieh TY (2003). Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 39:728-735. (Pubitemid 36930121)
19. Shimura H, Haraguchi K, Endo T, Onaya T (1997). Regulation of thyrotropin receptor gene expression in 3T3-L1 adipose cells is distinct from its regulation in FRTL-5 thyroid cells. Endocrinology 138:1483-1490. (Pubitemid 27137097)
20. Tilakaratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S (2006). Oral submucous fibrosis: review on aetiology and pathogenesis. Oral Oncol 42:561-568. (Pubitemid 43965004)
21. Vanderheyden P, Gies JP, Ebinger G, De Keyser J, Landry Y, Vauquelin G (1990). Human M1-, M2- and M3-muscarinic cholinergic receptors: binding characteristics of agonists and antagonists. J Neurol Sci 97:67-80. (Pubitemid 20190525)
22. Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS (2004). Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol 47:89-94.
23. Yang YR, Chang KC, Chen CL, Chiu TH (2000). Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol 43:23-28.